MC1424A1 - Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique - Google Patents

Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique

Info

Publication number
MC1424A1
MC1424A1 MC811558A MC1558A MC1424A1 MC 1424 A1 MC1424 A1 MC 1424A1 MC 811558 A MC811558 A MC 811558A MC 1558 A MC1558 A MC 1558A MC 1424 A1 MC1424 A1 MC 1424A1
Authority
MC
Monaco
Prior art keywords
interferons
hybrid human
microbiological preparation
human leucocytes
host organisms
Prior art date
Application number
MC811558A
Other languages
English (en)
Inventor
Goeddel David Van Norman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MC1424A1 publication Critical patent/MC1424A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MC811558A 1980-11-10 1981-11-09 Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique MC1424A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (1)

Publication Number Publication Date
MC1424A1 true MC1424A1 (fr) 1982-10-18

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811558A MC1424A1 (fr) 1980-11-10 1981-11-09 Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique

Country Status (34)

Country Link
EP (1) EP0051873B1 (fr)
JP (1) JP2642291B2 (fr)
KR (1) KR920007439B1 (fr)
AT (1) ATE46718T1 (fr)
AU (1) AU555293B2 (fr)
BR (1) BR8107293A (fr)
CA (2) CA1212915A (fr)
CH (2) CH663032A5 (fr)
DE (2) DE3144469A1 (fr)
DK (1) DK173590B1 (fr)
DO (1) DOP1981004064A (fr)
DZ (1) DZ350A1 (fr)
ES (2) ES506955A0 (fr)
FI (1) FI79550C (fr)
FR (1) FR2493867B1 (fr)
GB (1) GB2090258B (fr)
GR (1) GR81947B (fr)
HK (1) HK51685A (fr)
IE (1) IE51850B1 (fr)
IL (1) IL64243A (fr)
IT (1) IT1169276B (fr)
KE (1) KE3536A (fr)
LU (1) LU83745A1 (fr)
MC (1) MC1424A1 (fr)
MY (2) MY8700710A (fr)
NL (1) NL189092C (fr)
NO (1) NO165201C (fr)
NZ (1) NZ198906A (fr)
PH (1) PH18565A (fr)
PL (1) PL233748A1 (fr)
PT (1) PT73955B (fr)
SE (1) SE460539B (fr)
YU (1) YU46597B (fr)
ZW (1) ZW26981A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
JPS58501543A (ja) * 1981-08-14 1983-09-16 エイ／エス　アルフレツド　ベンツオン ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良
EP0072541A3 (fr) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Interferons de leucocytes humains, procédé pour leur production microbiologique, intermédiaires et compositions les contenant
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
IT1167610B (it) * 1982-01-19 1987-05-13 Cetus Corp Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
WO1984003300A1 (fr) * 1983-02-24 1984-08-30 Inst Organicheskogo Sinteza Ak Interferon n humain leucocytaire et son procede d'obtention dans des cellules bacteriennes
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
EP0146903A3 (fr) * 1983-12-19 1987-07-22 Schering Corporation Production d'un vecteur qui encode un interféron hybride
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (fr) * 1984-08-31 1986-03-12 University Patents, Inc. Interférons humains d'hybrides de lymphoblastoides-leucocytes
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
EP0240550A4 (fr) * 1985-09-26 1989-09-19 Genetics Inst Proteines tensio-actives pulmonaires.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
EP0490233A1 (fr) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Anticorps monoclonaux contre les interférons hybrides Bgl III, leur application et leur procédé de préparation
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (fr) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Préparation pour le traitement du cancer de la vessie
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
EP0830368A1 (fr) 1995-06-07 1998-03-25 Genta Incorporated Nouveaux lipides cationiques a base de carbamate
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
WO2005113592A2 (fr) 2004-05-19 2005-12-01 Maxygen, Inc. Polypeptides et conjugues interferon-alpha
BRPI0609809A2 (pt) 2005-05-18 2011-10-11 Maxygen Inc polipeptìdeo isolado ou recombinante, conjugado, composição, polinucleotìdeo isolado ou recombinante, célula hospedeira, vetor, métodos para preparar o polipeptìdeo, para preparar um conjugado, para inibir replicação de um vìrus em células infectadas com o vìrus para reduzir o numero de cópias de um vìrus em células infectadas com o vìrus, para reduzir o nìvel de rna de hcv no soro de um paciente infectado com hcv, para reduzir o nìvel de dna de hbv em soro de um paciente infectado com hbv e para reduzir o nìvel de rna de hiv em soro de um paciente infectado com hiv, e, uso do polipeptìdeo ou do conjugado

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165463D1 (en) * 1980-01-08 1984-09-20 Biogen Nv Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides

Also Published As

Publication number Publication date
IL64243A0 (en) 1982-02-28
FI813539L (fi) 1982-05-11
ES512354A0 (es) 1983-03-01
GR81947B (fr) 1984-12-12
FI79550C (fi) 1990-01-10
MY8800066A (en) 1988-12-31
DK173590B1 (da) 2001-04-02
PH18565A (en) 1985-08-09
GB2090258B (en) 1984-05-02
KR920007439B1 (ko) 1992-09-01
PT73955B (en) 1983-11-23
NL189092B (nl) 1992-08-03
FI79550B (fi) 1989-09-29
YU265681A (en) 1984-08-31
IL64243A (en) 1985-11-29
CH660743A5 (de) 1987-06-15
KR830007825A (ko) 1983-11-07
BR8107293A (pt) 1982-08-03
EP0051873B1 (fr) 1989-09-27
AU555293B2 (en) 1986-09-18
JPH07308191A (ja) 1995-11-28
NZ198906A (en) 1985-12-13
ATE46718T1 (de) 1989-10-15
NO813785L (no) 1982-05-11
MY8700710A (en) 1987-12-31
DE3144469A1 (de) 1982-09-02
IT8124967A0 (it) 1981-11-10
IT1169276B (it) 1987-05-27
NO165201C (no) 1991-01-16
ES8302778A1 (es) 1983-02-01
DK494681A (da) 1982-05-11
AU7730481A (en) 1982-05-20
JP2642291B2 (ja) 1997-08-20
NL189092C (nl) 1993-01-04
DZ350A1 (fr) 2004-09-13
LU83745A1 (de) 1983-09-01
IE812622L (en) 1982-05-10
PL233748A1 (en) 1983-07-18
DE3177106D1 (en) 1989-11-02
SE8106641L (sv) 1982-06-24
ES506955A0 (es) 1983-02-01
ES8304200A1 (es) 1983-03-01
PT73955A (en) 1981-12-01
SE460539B (sv) 1989-10-23
FR2493867A1 (fr) 1982-05-14
GB2090258A (en) 1982-07-07
EP0051873A2 (fr) 1982-05-19
KE3536A (en) 1985-06-07
DOP1981004064A (es) 1988-03-16
NO165201B (no) 1990-10-01
NL8105078A (nl) 1982-06-01
CA1277616C (fr) 1990-12-11
FR2493867B1 (fr) 1986-06-27
EP0051873A3 (en) 1982-09-22
CH663032A5 (de) 1987-11-13
ZW26981A1 (en) 1982-06-02
CA1212915A (fr) 1986-10-21
YU46597B (sh) 1994-01-20
IE51850B1 (en) 1987-04-15
HK51685A (en) 1985-07-12

Similar Documents

Publication Publication Date Title
MC1424A1 (fr) Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
IE811463L (en) Interferons
NO833464L (no) Dna sekvenser, rekombinant dna molekyler og fremgangsmaater ved fremstilling av svinevekst hormonliknende polypeptider
BR8205954A (pt) Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
JPS55131399A (en) Cultivation of namalva cell and replacing animal serum protein by human albumine for producing interferon by said cell
EP0072541A3 (fr) Interferons de leucocytes humains, procédé pour leur production microbiologique, intermédiaires et compositions les contenant
DE3177281D1 (de) Strukturgene, die fuer die verschiedenen allelischen und reifungsformen von praeprothaumatin und deren mutanten kodieren, diese strukturgene enthaltende klonierungsvektoren und deren expression in mikrobiellen wirtzellen.

Legal Events

Date Code Title Description
YP Annual fee paid